Harvard Corporate Governance

JULY 28, 2023

Posted by Carey Oven, Caroline Schoenecker, (Deloitte & Touche LLP) and Cid Wilson (Hispanic Association on Corporate Responsibility) , on Friday, July 28, 2023 Editor's Note: Carey Oven is National Managing Partner at the Center for Board Effectiveness and Chief Talent Officer, Caroline Schoenecker is an Experience Director at Deloitte & Touche LLP and Cid Wilson is the President and CEO of the Hispanic Association on Corporate Responsibility.

189

189

BVR

JULY 28, 2023

The regulation history of cannabis in the United States is a complex one, as are the valuation issues that stem from its status at the federal level. The following excerpt delves into some of the recent reforms on the legislative side of things.

Appraisal 100

Appraisal 100

Harvard Corporate Governance

JULY 28, 2023

Posted by the Harvard Law School Forum on Corporate Governance, on Friday, July 28, 2023 Editor's Note: This roundup contains a collection of the posts published on the Forum during the week of July 21-27, 2023. BlackRock to Expand Proxy Voting Choice to Its Largest ETF Posted by Joud Abdel Majeid, Salim Ramji and Jessica Burt, BlackRock Inc., on Friday, July 21, 2023 Tags: Asset management , Board of Directors , ETFs , Investment Stewardship , Proxy voting , voting choice SEC’s Approach to Enfo

Compliance 177

Compliance Marketability 177

Mckinsey and Company

JULY 28, 2023

Attempting to serve all corporate clients through high-touch, personal interactions isn’t meeting the needs of today’s customers. The key to full coverage is a multipronged model of banking channels.

Banking 98

Banking 98

Speaker: Susan Spencer, Principal of Spencer Communications

Intent signal data can go a long way toward shortening sales cycles and closing more deals. The challenge is deciding which is the best type of intent data to help your company meet its sales and marketing goals. In this webinar, Susan Spencer, fractional CMO and principal of Spencer Communications, will unpack the differences between contact-level and company-level intent signals.

Marketability

Benzinga

JULY 28, 2023

The S&P 500 and other major indexes slid on Thursday but recovered on Friday to wrap up the week to the upside. The Dow Jones broke a 13-day winning streak Thursday, its best since 1987, and was up 0.65% on a weekly basis Friday. The Nasdaq Composite posted a weekly gain of 1.67%. The Fed decided to relaunch its rate-hike campaign at the latest FOMC meeting, pushing the federal funds rate to 5.25%-5.5%.

Marketability 96

Marketability Equity 96

Mckinsey and Company

JULY 28, 2023

Organizations that successfully pull off a high-performing transformation don’t choose between either holistic performance or business reinvention. They pursue both.

98

98

Mckinsey and Company

JULY 28, 2023

Space junk refers to fragments left behind in space. Most space junk is debris from rocket-launching material and disused satellites.

98

98

National Law Review M&A

JULY 28, 2023

Nicole L. Castle Jon B. Dubrow Noah Feldman Greene Gregory E. Heltzer Jurisdiction: All Federal Joel R. Grosberg Type of Law: Antitrust & Trade Regulation Mergers & Acquisitions Raymond A. Jacobsen, Jr.

73

73

Mckinsey and Company

JULY 28, 2023

Consumer attitudes toward electric vehicles are changing fast—and so are expectations of the car-purchasing experience.

98

98

Financial Times M&A

JULY 28, 2023

Amsterdam-based online travel group seeks to overcome competition concerns around purchase of Swedish flights site

90

90

Speaker: Wayne Spivak - President and Chief Financial Officer of SBA * Consulting LTD, Industry Writer, and Public Speaker

The old adages that "cash is king" and "you can’t spend profits" still hold true today. But however well-known these sayings might be, it requires a change in mindset to properly implement a cash flow management system that predicts your business's runaway as accurately as possible. Key to this new mindset is understanding the difference between the Statement of Cash Flows, a historical look at the source and uses of cash, and the Cash Flow Statement, which uses transaction history and forward-l

Corporate Finance

Mckinsey and Company

JULY 28, 2023

Russia’s war in Ukraine grinds on. In this update, we map the latest social and economic consequences.

Corporate Finance 98

Corporate Finance Finance 98

Law 360 M&A

JULY 28, 2023

The National Football League sidelined one of its biggest legal headaches with an immediate imposition of a $60 million fine on Daniel Snyder following the $6 billion sale of his Washington Commanders, but concerns raised about the league's conduct throughout the dark chapter signal continued liability issues.

75

75

Mckinsey and Company

JULY 28, 2023

Despite encouraging macroeconomic and consumption indicators in the first half of 2023, we are unlikely to see a substantial surge in consumption in the near term.

75

75

Law 360 M&A

JULY 28, 2023

A Tennessee federal judge issued a stay in a consolidated investor class action accusing health program company Tivity Health of misleading investors about its $1.3 billion acquisition of weight-loss meal delivery company Nutrisystem, giving Tivity time to appeal the certification of class for a second time.

75

75

Speaker: Joe Apfelbaum, CEO of Ajax Union

In this webinar, Joe Apfelbaum, CEO of Ajax Union and business strategist, will take you through the ABCs of intent data. You'll learn how to effectively use it to drive business results, with practical tips on how to leverage both company and contact intent data to maximize your marketing efforts. Whether you're a seasoned marketer or just getting started, this webinar is a must-attend for anyone looking to stay ahead in the ever-evolving world of digital marketing.

Marketability

Appraisers Blog

JULY 28, 2023

Thank you for your efforts. NCREAA and NCPAC proposed a similar idea to our board 6 years ago. It was discussed and “tabled” for review. Disappeared of course. Good luck and please keep up the good fight as things get more desperate by the day.

Appraisal 64

Appraisal 64

Peak Business Valuation

JULY 28, 2023

Bars and nightclubs primarily provide alcoholic beverages to consumers. Many establishments in the bar and nightclub industry also serve food and nonalcoholic beverages. Bars and nightclubs may also include recreational activities such as dancing and billiards. Despite economic challenges in recent years, this industry has experienced healthy growth.

Business Valuation 52

Business Valuation EBITDA Fair Market Value Appraisal 52

Appraisers Blog

JULY 28, 2023

Doug V After reading all these blogs, and agreeing with you all I think “do we do it their way or USPAP’s way” Isn’t their way Misleading by Omission?

Appraisal 55

Appraisal 55

Peak Business Valuation

JULY 28, 2023

The fitness industry has struggled over the past several years due to social distancing regulations as well as intense competition. As a result, we have seen a decline in sales revenue and profit for many gyms across the United States. Moving forward, these effects will likely reverse as the economy recovers from the pandemic. This is ideal if you are looking to buy , grow , or sell a gym.

Business Valuation 52

Business Valuation Appraisal Fair Market Value Marketability 52

Benzinga

JULY 28, 2023

AstraZeneca Plc's (NASDAQ: AZN ) unit Alexion has agreed to buy Pfizer Inc's (NYSE: PFE ) preclinical gene therapy programs and enabling technologies for up to $1 billion, plus royalties on sales. AstraZeneca bought Alexion in 2021. It focuses on rare diseases, AstraZeneca said. It plans to close the deal in the third quarter. The deal will bring a number of novel adeno-associated virus (AAV) capsids to Alexion and help build on Alexion and AstraZeneca's capabilities in genomic medic

Technology 52

Technology 52

Auto Dealer Valuation Insights

JULY 28, 2023

Karolina Calhoun, CPA, ABV, CFF and David W. R. Harkins, CFA, ABV will be attending the American Bar Association’s 35th Annual Family Law Trial Advocacy Institute on Thursday, July 27, 2023 – Saturday, July 29, 2023, at the UMKC School of Law, in Kansas City, Missouri. Karolina Calhoun, Vice President, has been involved with hundreds of valuation and litigation support engagements in a diverse.

52

52

Benzinga

JULY 28, 2023

Biogen Inc (NASDAQ: BIIB ) has agreed to acquire Reata Pharmaceuticals Inc (NASDAQ: RETA ) for $172.50 per share in cash, reflecting an enterprise value of approximately $7.3 billion. Reata's FDA-approved Skyclarys (omaveloxolone) is the first and only approved treatment for Friedreich's ataxia (FA) in the U.S., with a commercial launch and a European regulatory review ongoing.

Enterprise Value 52

Enterprise Value 52

Auto Dealer Valuation Insights

JULY 28, 2023

ExxonMobil made waves in the energy M&A markets by announcing its acquisition of Denbury, Inc. Exxon paid somewhere between Denbury’s stock price and a slight premium depending on the timing and stock price fluctuations. In total, the headline value was around $4.9 billion, according to Exxon’s news release. However, while Denbury is an energy company on the whole, it is made up of two main.

Marketability 52

Marketability Mergers & Acquisitions 52

Benzinga

JULY 28, 2023

Biogen (NASDAQ: BIIB ) has announced an acquisition of Reata Pharmaceuticals (NASDAQ: RETA ) that is expected to be completed in Q4 of 2023. Under the terms of the agreement, Biogen has agreed to give Reata Pharmaceuticals $7.30 billion in cash in exchange for RETA stock. About The Companies Involved Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan.

Marketability 52

Marketability 52

Law 360 M&A

JULY 28, 2023

A California federal judge on Thursday tossed a 7-year-old investor suit against prenatal diagnostic company Sequenom Inc., saying the investors show no facts that the board misled investors by approving LabCorp's $371 million takeover at $2.40 per share, but ruled the plaintiffs can amend the suit and try again.

52

52

Benzinga

JULY 28, 2023

Earlier today, Biogen Inc (NASDAQ: BIIB ) agreed to acquire Reata Pharmaceuticals Inc (NASDAQ: RETA ) for $172.50 per share in cash, reflecting an enterprise value of approximately $7.3 billion. William Blair analysts Myles Minter, Sarah Schram and Tiffany Marchell view the acquisition, although not inexpensive, as fitting the company's previously described acquisition goals of de-risked, value-added and accretive assets.

Enterprise Value 52

Enterprise Value 52

Law 360 M&A

JULY 28, 2023

A Syneos Health Inc. shareholder alleges the company's leadership lied about its booming business during the COVID-19 pandemic when, in reality, a series of poor decisions caused the business to flounder, according to a proposed securities class action filed in New York federal court.

52

52

Benzinga

JULY 28, 2023

The private fintech company, Upgrade, Inc. , disclosed the acquisition of Uplift, Inc. for $100 million in cash and stock transaction. Uplift offers Buy Now Pay Later (BNPL) payment and credit products to travelers, currently serving 3.3 million customers in collaboration with over 300 of airlines, cruise lines, and hotel companies in the U.S. and Canada.

52

52

Sun M&A

JULY 28, 2023

When you are ready to sell your business, your top concerns are finding a buyer and maximizing the company’s value. However, this is often easier said than done. It’s hard to run a business while doing everything that leads to a successful sales transaction, like verifying the buyer’s financial capacity and ensuring that the sale complies with all legal requirements.

Business Valuation 52

Business Valuation Marketability 52

Mckinsey and Company

JULY 28, 2023

Russia’s war in Ukraine grinds on. In this update, we map the latest social and economic consequences.

Corporate Finance 75

Corporate Finance Finance 75

Benchmark Report

JULY 28, 2023

In recent years there has been a significant degree of volatility in the market, but it is generally agreed that we will likely enter a “buyer’s market” soon.

Marketability 52

Marketability 52

Appraisers Blog

JULY 28, 2023

Who is going to organize raising funds & hiring a lobbyist? We are woefully behind the curve here. So my fellow appraisers who has the plan?

Appraisal 54

Appraisal 54

Benzinga

JULY 28, 2023

SKYCLARYS ® recently approved in US as the only treatment indicated for patients with Friedreich's ataxia Proposed acquisition represents meaningful step forward in Biogen's strategy for sustainable growth, adding a highly complementary innovative product in an area of high unmet medical need Expected to be significantly accretive to Biogen's Non-GAAP diluted EPS beginning in 2025 Biogen to host investor conference call today at 9:00 a.m.

Enterprise Value 40

Enterprise Value Finance 40

Appraisers Blog

JULY 28, 2023

I wish Washington State had similar views. I would love to flush the crappy AMC’s out. The ones that offer a service and transparency I suppose could stay.

Appraisal 50

Appraisal 50

Benzinga

JULY 28, 2023

DEERFIELD, Ill., July 28, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (OTC: SRGAQ ) ("Surgalign" or the "Company"), a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that following a competitive court-supervised marketing and sale process, including a competitive auction, the Company has selected Xtant Medical Holdings, Inc.

Technology 40

Technology Marketability 40